Author:
Leng Jing,Tian Hua-jie,Fang Yi,Hu Yi-yang,Peng Jing-hua
Abstract
Gut-derived lipopolysaccharide (LPS) leaking through the dysfunctional intestinal barrier contributes to the onset of non-alcoholic steatohepatitis (NASH) by triggering inflammation in the liver. In the present study, a combination consisting of Atractylodes macrocephala polysaccharide (A), chlorogenic acid (C), and geniposide (G) (together, ACG), was shown to ameliorate NASH in mice and reduce hepatic LPS signaling and endotoxemia without decreasing the abundance of identified Gram-negative bacteria through restoring the intestinal tight junctions. Our data indicated that inhibition of LPS gut leakage by the ACG combination contributed to its amelioration of NASH.
Subject
Infectious Diseases,Microbiology (medical),Immunology,Microbiology
Reference50 articles.
1. Alcohol, Liver Disease and the Gut Microbiota;Bajaj;Nat. Rev. Gastroenterol. Hepatol,2019
2. Turicibacter Sanguinis Gen. Nov., Sp. Nov., a Novel Anaerobic, Gram-Positive Bacterium;Bosshard;Int. J. Syst. Evol. Microbiol.,2002
3. Expert Consensus on TCM Diagnosis and Treatment of Nonalcoholic Fatty Liver Disease (2017);J. Clin. Hepatol.,2017
4. Gut Microbial Metabolites in Obesity, NAFLD and T2DM;Canfora;Nat. Rev. Endocrinol,2019
5. The Diagnosis and Management of Nonalcoholic Fatty Liver Disease: Practice Guidance From the American Association for the Study of Liver Diseases;Chalasani;Hepatology,2018
Cited by
10 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献